ACTRN12610000147088已完成4 期
A Randomized, Blinded, Multicentre Non-inferiority Study Comparing the Acid-base Effects of Plasmalyte and Hartmann’s solution in Patients undergoing Liver Resection
Austin Hospital0 个研究点目标入组 50 人开始时间: 2010年2月12日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Adult patients having elective liver resection surgery
排除标准
- •1. Patient declines to take part
- •2. Age less than 18 years
- •3. Abnormal pre-operative coagulopathy: INR (international normalised ratio) > 1.4, platelet count < 75 x 109/l
- •4. Severe hepatic insufficiency (bilirubin > 30umol/L, ALP (alkaline phosphatase) >300iu/L, ALT (alanine transaminase) > 50iu/L, albumin < 25g/dL, INR > 1.5
- •5. Moderate/severe renal impairment: serum creatinine > 200ummol/l
- •6. Hyperkalaemia (serum potassium > 5.6)
- •7. American Society of Anaesthesiologists (ASA) physical status IV or V
- •7. Patients with a known previous allergic reaction to study solutions
研究者
相似试验
进行中（未招募）
不适用
A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with ImpetigoMedDRA version: 7.1Level: PTClassification code 10021531ImpetigoEUCTR2004-004439-70-DEGlaxSmithKline Research & Development520
进行中（未招募）
不适用
A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with ImpetigoTreatment of the impetigoMedDRA version: 6.1Level: PTClassification code 10021531EUCTR2004-004439-70-ITGLAXO SMITHKLINE520
进行中（未招募）
不适用
A Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Myozyme, Recombinant Human Acid alpha-Glucosidase (rhGAA), Treatment in Patients with Late-Onset Pompe Disease - LOTSGlycogen Storage Disease type II (Pompe's disease)MedDRA version: 9.1Level: LLTClassification code 10036143Term: Pompe's diseaseEUCTR2005-002759-42-DEGenzyme Europe BV90
尚未招募
3 期
To Evaluate the efficacy and Safety of a test vaccine (Tetanus, diphtheria, pertussis) in comparison to a marketed vaccine in healthy Subjects Aged 4-65 years.CTRI/2024/06/068559Techinvention Lifecare Pvt Ltd
尚未招募
3 期
A Randomized, Double-Blind, Multicenter, Equivalence Study of ONS-3010 and Humira® for the Treatment of Patients with Moderate to Severe Plaque Psoriasisplaque psoriasisrecurrent skin disease with chapped and dry skin10040790NL-OMON42923Oncobiologics Limited50